Total Payments
$1,611
2023 Payments
$53.86
Companies
26
Transactions
99
Medicare Patients
909
Medicare Billing
$91,650
Payment Breakdown by Category
Food & Beverage$1,611 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,611 | 99 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $366.74 | 22 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $272.29 | 15 | $0 (2022) |
| Eisai Inc. | $126.50 | 9 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $120.65 | 6 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $104.01 | 6 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $65.36 | 4 | $0 (2023) |
| PFIZER INC. | $62.63 | 5 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $56.39 | 3 | $0 (2022) |
| Lilly USA, LLC | $54.37 | 4 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $49.11 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $53.86 | 3 | Supernus Pharmaceuticals, Inc. ($38.70) |
| 2022 | $164.37 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($42.57) |
| 2021 | $1,392 | 87 | AbbVie Inc. ($313.73) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $20.25 | General |
| Category: PSYCHOLOGY | ||||||
| 04/19/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $18.45 | General |
| Category: PSYCHOLOGY | ||||||
| 01/10/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Gastroenterology | ||||||
| 02/08/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Diabetes Care | ||||||
| 02/08/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Cardio-renal | ||||||
| 02/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: DIABETES | ||||||
| 01/25/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: DIABETES | ||||||
| 01/24/2022 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 01/21/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: DIABETES | ||||||
| 12/20/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Gastroenterology | ||||||
| 12/07/2021 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/29/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Neuroscience | ||||||
| 11/18/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $14.38 | General |
| Category: Neurology | ||||||
| 11/16/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Cardio-renal | ||||||
| 11/12/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: DIABETES | ||||||
| 11/09/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: DIABETES | ||||||
| 11/02/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/29/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: DIABETES | ||||||
| 10/19/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Diabetes | ||||||
| 10/18/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $21.79 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 413 | 531 | $87,741 | $54,659 |
| 2022 | 1 | 17 | 18 | $5,814 | $1,030 |
| 2021 | 7 | 258 | 365 | $89,818 | $21,862 |
| 2020 | 6 | 221 | 319 | $74,956 | $14,099 |
Total Patients
909
Total Services
1,233
Medicare Billing
$91,650
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 116 | 124 | $36,456 | $22,885 | 62.8% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 78 | 96 | $18,912 | $11,860 | 62.7% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 75 | 112 | $15,120 | $9,484 | 62.7% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 58 | 95 | $7,695 | $4,816 | 62.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 25 | 26 | $5,642 | $3,543 | 62.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 17 | 24 | $1,440 | $776.88 | 53.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 15 | 21 | $1,313 | $684.41 | 52.1% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 11 | 15 | $731.25 | $394.53 | 54.0% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 18 | 18 | $432.00 | $215.73 | 49.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 18 | $5,814 | $1,030 | 17.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 115 | 196 | $63,308 | $14,484 | 22.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 59 | 80 | $17,440 | $4,096 | 23.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 14 | 14 | $4,746 | $1,574 | 33.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 18 | 18 | $1,620 | $1,170 | 72.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 20 | 20 | $1,200 | $339.74 | 28.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 17 | 18 | $1,314 | $154.56 | 11.8% |
| 81003 | Automated urinalysis test | Office | 2021 | 15 | 19 | $190.00 | $42.75 | 22.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 91 | 159 | $51,357 | $9,370 | 18.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 69 | 91 | $19,838 | $3,441 | 17.3% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 15 | 15 | $1,350 | $896.43 | 66.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 16 | 16 | $960.00 | $266.85 | 27.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 13 | 17 | $1,241 | $77.27 | 6.2% |
| 81003 | Automated urinalysis test | Office | 2020 | 17 | 21 | $210.00 | $46.90 | 22.3% |
About Sara Roark, NP
Sara Roark, NP is a Family healthcare provider based in Irving, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/18/2013. The National Provider Identifier (NPI) number assigned to this provider is 1710227418.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sara Roark, NP has received a total of $1,611 in payments from pharmaceutical and medical device companies, with $53.86 received in 2023. These payments were reported across 99 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,611).
As a Medicare-enrolled provider, Roark has provided services to 909 Medicare beneficiaries, totaling 1,233 services with total Medicare billing of $91,650. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Irving, TX
- Active Since 02/18/2013
- Last Updated 05/23/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1710227418
Products in Payments
- JARDIANCE (Drug) $286.66
- VRAYLAR (Drug) $252.56
- Dayvigo (Drug) $126.50
- NURTEC ODT (Drug) $120.65
- TRINTELLIX (Drug) $104.01
- UBRELVY (Drug) $79.80
- QELBREE (Drug) $65.36
- XIFAXAN (Drug) $56.39
- Kerendia (Drug) $49.11
- MYRBETRIQ (Drug) $42.01
- EMGALITY (Drug) $40.00
- PREMARIN (Drug) $34.40
- QULIPTA (Drug) $34.38
- ENTRESTO (Drug) $29.87
- Ozempic (Drug) $28.41
- JATENZO (Drug) $28.39
- ELIQUIS (Drug) $28.23
- FREESTYLE LIBRE (Device) $22.56
- AZSTARYS (Drug) $21.12
- INVEGA SUSTENNA (Drug) $18.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Irving
Mrs. Delara Pollman, Aprn-Cnp, APRN-CNP
Family — Payments: $5,071
Family $5,071
Kierra Smith
Family — Payments: $4,393
Family $4,393
Ranbir Sidhu
Family — Payments: $3,550
Family $3,550
Sigimol Joseph, Fnp, FNP
Family — Payments: $3,362
Family $3,362
Consuelo Alanis, Msn, Aprn, Fnp-Bc, MSN, APRN, FNP-BC
Family — Payments: $3,071
Family $3,071
Alexandra Clark, Anp, ANP
Family — Payments: $2,597
Family $2,597